A 1 GLY 0 -1.952 -1.727 <=B
A 2 SER 17 -6.346 -7.571
A 3 ASN 9 -9.634 -9.561
A 4 LYS 4 -11.097 -10.281
A 5 PHE 20 -12.563 -13.418
A 6 HIS 6 -13.821 -12.921
A 7 CYS 21 -16.374 -16.906
A 8 ASP 20 -15.152 -15.710
A 9 VAL 22 -15.395 -16.155
A 10 CYS 16 -15.574 -15.623
A 11 SER 0 -14.897 -13.184
A 12 ALA 18 -14.851 -15.213
A 13 ASP 5 -13.341 -12.381
A 14 CYS 26 -14.189 -15.547
A 15 THR 7 -11.946 -11.377
A 16 ASN 10 -12.245 -11.987
A 17 ARG 16 -13.068 -13.405
A 18 VAL 10 -13.679 -13.256
A 19 ARG 23 -14.831 -15.770
A 20 VAL 21 -15.326 -15.979
A 21 SER 18 -14.484 -14.889
A 22 CYS 24 -13.216 -14.456
A 23 ALA 6 -10.700 -10.160
A 24 ILE 10 -10.034 -10.030
A 25 CYS 20 -11.201 -12.213
A 26 PRO 0 -10.229 -9.053
A 27 GLU 5 -11.288 -10.565
A 28 TYR 22 -13.486 -14.466
A 29 ASP 19 -15.021 -15.479
A 30 LEU 27 -16.543 -17.746
A 31 CYS 15 -16.949 -16.725
A 32 VAL 8 -15.341 -14.497
A 33 PRO 10 -14.379 -13.875
A 34 CYS 26 -15.671 -16.859
A 35 PHE 22 -14.832 -15.657
A 36 SER 5 -12.830 -11.930
A 37 GLN 13 -12.343 -12.418
A 38 GLY 1 -12.164 -10.880
A 39 SER 18 -13.350 -13.884
A 40 TYR 17 -12.669 -13.167
A 41 THR 14 -11.913 -12.153
A 42 GLY 14 -9.724 -10.216
A 43 LYS 5 -8.298 -7.919
A 44 HIS 24 -10.464 -12.020
A 45 ARG 4 -10.081 -9.382
A 46 PRO 10 -11.000 -10.885
A 47 TYR 0 -9.129 -8.079
A 48 HIS 23 -9.929 -11.432
A 49 ASP 2 -9.559 -8.690
A 50 TYR 23 -11.357 -12.696
A 51 ARG 12 -11.496 -11.554
A 52 ILE 7 -12.024 -11.446
A 53 ILE 20 -12.173 -13.073
A 54 GLU 9 -11.909 -11.575
A 55 THR 18 -11.261 -12.036
A 56 ASN 11 -7.394 -7.809
A 57 SER 10 -5.543 -6.055
A 58 TYR 7 -4.483 -4.772
A 59 PRO 8 -2.311 -2.965 <=B
A 60 ILE 19 -2.893 -4.745
A 61 LEU 27 -2.731 -5.522
A 62 CYS 16 -2.443 -4.002
A 63 PRO 0 -1.606 -1.421 <=B
A 64 ASP 10 -0.850 -1.902 <=B
A 65 TRP 26 -2.018 -4.776
A 66 GLY 14 -3.256 -4.492
A 67 ALA 9 -3.936 -4.519
A 68 ASP 16 -4.858 -6.140
A 69 GLU 25 -1.720 -4.397
A 70 GLU 20 -2.705 -4.694
A 71 LEU 10 -2.804 -3.631 <=B
A 72 GLN 28 -1.895 -4.897
A 73 LEU 30 -2.490 -5.653
A 74 ILE 15 -1.759 -3.282 <=B
A 75 LYS 12 -1.725 -2.907 <=B
A 76 GLY 27 -1.174 -4.144
A 77 ALA 20 -2.003 -4.072
A 78 GLN 7 -2.303 -2.843 <=B
A 79 THR 13 -1.061 -2.434 <=B
A 80 LEU 21 -0.908 -3.218 <=B
A 81 GLY 4 -1.596 -1.873 <=B
A 82 LEU 8 -2.830 -3.424 <=B
A 83 GLY 1 -1.712 -1.630 <=B
A 84 ASN 15 -0.672 -2.320 <=B
A 85 TRP 12 -1.170 -2.416 <=B
A 86 GLN 0 -0.757 -0.670 <=B
A 87 ASP 11 0.966 -0.410 <=B
A 88 ILE 27 -0.397 -3.457 <=B
A 89 ALA 13 0.328 -1.204 <=B
A 90 ASP 10 0.388 -0.806 <=B
A 91 HIS 24 -0.294 -3.020 <=B
A 92 ILE 33 -0.756 -4.464
A 93 GLY 11 0.251 -1.043 <=B
A 94 SER 13 -0.153 -1.630 <=B
A 95 ARG 30 -0.132 -3.567 <=B
A 96 GLY 3 0.314 -0.067 <=B
A 97 LYS 8 -0.153 -1.056 <=B
A 98 GLU 0 -0.024 -0.021 <=B
A 99 GLU 16 -0.118 -1.944 <=B
A 100 VAL 29 -0.941 -4.168
A 101 LYS 8 -0.954 -1.764 <=B
A 102 GLU 8 -0.955 -1.765 <=B
A 103 HIS 30 -1.557 -4.828
A 104 TYR 24 -2.213 -4.718
A 105 LEU 9 -2.285 -3.058 <=B
A 106 LYS 12 -1.662 -2.851 <=B
A 107 TYR 24 -2.320 -4.813
A 108 TYR 21 -2.547 -4.669
A 109 LEU 12 -2.657 -3.732
A 110 GLU 6 -2.214 -2.650 <=B
A 111 SER 17 -2.306 -3.996
A 112 LYS 4 -2.314 -2.508 <=B
A 113 TYR 7 -2.091 -2.655 <=B
A 114 TYR 9 -2.171 -2.956 <=B
A 115 PRO 0 -2.763 -2.445 <=B
A 116 ILE 4 -3.258 -3.343 <=B
A 117 PRO 18 -2.888 -4.626
A 118 ASP 8 -2.444 -3.083 <=B
A 119 ILE 8 -2.998 -3.574 <=B
A 120 THR 3 -2.329 -2.406 <=B

Identified 41 B-Cell epitope residues out of 120 total residues